Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism

Area of Science:

• Neuroscience
• Biomedical Engineering
• Developmental Pediatrics

Background:

• Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder affecting 1 in 166 children in the U.S.
• Autistic individuals often exhibit cerebral hypoperfusion, neuroinflammation, immune dysregulation, oxidative stress, mitochondrial dysfunction, and gut dysbiosis.
• These physiological abnormalities are frequently correlated with core autistic symptoms, including social, communication, and behavioral impairments.

Purpose of the Study:

• To explore the potential therapeutic benefits of Hyperbaric Oxygen Therapy (HBOT) for individuals with autism.
• To investigate how HBOT may ameliorate the specific pathophysiological findings observed in autism.

Main Methods:

• Review of existing research on HBOT applications in conditions similar to those found in autism.
• Analysis of HBOT's proposed mechanisms of action, including anti-inflammatory effects, antioxidant upregulation, mitochondrial enhancement, and detoxification support.
• Consideration of HBOT's potential role in stem cell mobilization and neurogenesis.

Main Results:

• HBOT has demonstrated efficacy in conditions characterized by cerebral hypoperfusion.
• HBOT exhibits anti-inflammatory properties, improves immune function, and reduces oxidative stress.
• HBOT may enhance mitochondrial function, improve neurotransmitter balance, aid detoxification, and positively impact gut dysbiosis.

Conclusions:

• HBOT presents a promising therapeutic strategy for addressing multiple underlying biological deficits in autism.
• By improving cerebral blood flow, reducing inflammation, and enhancing cellular function, HBOT may lead to significant improvements in autistic symptoms.
• Further clinical studies are warranted, with early results for HBOT in autism being encouraging.